Stonebridge Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$696K Sell
1,652
-1,683
-50% -$671K 0.09% 130
2026
Q2
$1.21M Buy
+3,335
New +$1.14M 0.17% 96

Other funds holding AMGN

Stonebridge Financial Group's AMGN Position: Q3 2026 in Review

Stonebridge Financial Group reduced its Amgen (AMGN) stake by 50% in Q3 2026, selling an estimated $671K and leaving 1,652 shares worth $696K. The position accounts for 0.09% of the portfolio, ranked #130.

Stonebridge Financial Group first reported a position in AMGN in Q2 2026 and has held it in 2 quarters since. The position peaked at $1.21M in Q2 2026. 3,274 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Stonebridge Financial Group held 1,652 shares of Amgen worth $696K as of Q3 2026.
  • Stonebridge Financial Group sold 1,683 Amgen shares in Q3 2026, an estimated $671K.
  • Amgen made up 0.09% of Stonebridge Financial Group's portfolio in Q3 2026, its #130 holding.
  • Stonebridge Financial Group first reported a position in Amgen in Q2 2026 and has held it in 2 quarters since.
  • Stonebridge Financial Group's Amgen position peaked at $1.21M in Q2 2026.
  • 3,274 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Stonebridge Financial Group's 13F filing for Q3 2026, filed 12 Nov 2026.